ODS Strategic Plan
This article was originally published in The Tan Sheet
Open public meeting will be held May 8-9 at Marriott in Bethesda, Md., to receive input on revised Strategic Plan for 2004-2009, which is slated for publication in late 2003. "New initiative is reexamining the goals and objectives of the original report," which was prepared in 1997-1998, "reviewing the progress made [and] considering needs and opportunities for ODS program focus." Details will be available at 1ODS Web site on or before April 4...
You may also be interested in...
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.